Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA

• Published in: Clinical science (1979) Vol. 130; no. 21; p. 1955
• Main Authors: Tryggestad, Jeanie B, Vishwanath, Anu, Jiang, Shaoning, Mallappa, Ashwini, Teague, April M, Takahashi, Yusuke, Thompson, David M, Chernausek, Steven D
• Format: Journal Article
• Language: English
• Published: England 01-11-2016
• Subjects: Adult; Cross-Sectional Studies; Diabetes, Gestational - genetics; Diabetes, Gestational - metabolism; Female; Gene Expression Profiling; Human Umbilical Vein Endothelial Cells - metabolism; Humans; MicroRNAs - genetics; MicroRNAs - metabolism; Placenta - metabolism; Pregnancy; Trophoblasts - metabolism; Young Adult; miRNA; fetal programming; human umbilical vein endothelial cell (HUVEC); gestational diabetes
• ISSN: 1470-8736
• DOI: 10.1042/cs20160305

We aimed to identify miRNAs whose expression levels in fetal tissues are altered by exposure to a diabetic milieu and elucidate the impact on target protein expression. Gestational diabetes mellitus (GDM) affects both immediate and future disease risk in the offspring. We hypothesized that GDM alters miRNA expression in human umbilical vein endothelial cells (HUVECs) that may influence metabolic processes. A cross-sectional design compared differences in miRNA expression in HUVECs and target protein abundance in placentae between infants of women with GDM (IGDM) and infants born to normoglycaemic controls. miRNAs were identified using microarray profiling and literature review and validated by quantitative PCR (qPCR). In vitro transfection studies explored the impact of the miRNA on target protein expression. Expression of seven miRNA species, miR-30c-5p, miR-452-5p, miR-126-3p, miR-130b-3p, miR-148a-3p, miR-let-7a-5p and miR-let-7g-5p, was higher in the HUVECs of IGDM. Abundance of the catalytic subunit of AMP-activated protein kinase α1 (AMPKα1) was decreased in the HUVECs and BeWo cells (transformed trophoblast cell line) transfected with miR-130b and miR-148a mimics. AMPKα1 expression was also decreased in placental tissues of IGDM. The expression of several miRNAs were altered by in utero exposure to DM in infants of women whose dysglycaemia was very well controlled by current standards. Decreased expression of AMPKα1 as a result of increased levels of miR-130b and miR-148a may potentially explain the decrease in fat oxidation we reported in infants at 1 month of age and, if persistent, may predispose offspring to future metabolic disease.